Zyuds Lifesciences receives USFDA approval for DMD treatment drug
Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
Kiran Mazumdar-Shaw received the award from Janak Kumar Mehta, President of ISQ and Chairman & Managing Director, TQM International
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
Subscribe To Our Newsletter & Stay Updated